Who is eligible?
NSW residents who are patients of NSW public hospitals and are prescribed s100 injectable and infusible chemotherapy medicines under Section 100 of the National Health Act 1953 are eligible.
This includes public non-admitted patients, outpatients or day patients, inpatients on discharge from public hospitals and privately referred, non-admitted patients treated in NSW public hospitals.
Co-payments for s100 injectable and infusible chemotherapy medicines for patients who access care in the private sector in NSW remain the same.
The co-payment is paid for by the NSW Government for prescriptions filled at NSW public hospital pharmacies or through pharmacies used by NSW public hospital oncology services.
Why are co-payments paid by the NSW Government?
In March 2015, the NSW Government made the commitment to pay co-payments for both s100 injectable and infusible chemotherapy medicines and s100 Highly Specialised Drugs to help ease the financial burden for people with cancer and other chronic conditions.
This commitment benefits people living with cancer, as well as those with conditions such as HIV, patients with organ and tissue transplants, schizophrenia, hepatitis, Crohn’s disease, ulcerative colitis, cystic fibrosis, psoriatic and rheumatoid arthritis, and severe allergic asthma and rare diseases, particularly those affecting children, including juvenile idiopathic arthritis.
How do I fill my prescription?
Prescriptions for s100 injectable and infusible chemotherapy medicines can be filled through NSW public hospital pharmacies or pharmacies used by NSW public hospital oncology services.
Why do I have to fill in a consent form?
When your prescription is filled at pharmacies used by NSW public hospital oncology services you already sign a consent form. This form indicates your agreement for the NSW Government to pay the co-payment on your behalf and acknowledges that some details will be provided to NSW Health to make the co-payment and evaluate the program.
What are s100 injectable and infusible chemotherapy medicines?
Injectable and infusible chemotherapy is used for the treatment of cancers in hospitals by oncology services. Oral chemotherapy, taken by mouth, which are general items on the Pharmaceutical Benefits Scheme (PBS), are not affected by this commitment.
A full list of s100 injectable and infusible chemotherapy medicines is available on the Pharmaceutical Benefits Scheme website.
Patients should talk to their doctor or oncology service nurse about whether this commitment will affect them and their chemotherapy treatment.